Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sébastien Moutton is active.

Publication


Featured researches published by Sébastien Moutton.


Nature Neuroscience | 2015

Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects

Dennis Mircsof; Maéva Langouët; Marlène Rio; Sébastien Moutton; Karine Siquier-Pernet; Christine Bole-Feysot; Nicolas Cagnard; Patrick Nitschke; Ludmila Gaspar; Matej Žnidarič; Olivier Alibeu; Ann-Kristina Fritz; David P. Wolfer; Aileen Schröter; Giovanna Bosshard; Markus Rudin; Christina Koester; Florence Crestani; Petra Seebeck; Nathalie Boddaert; Katrina Prescott; Rochelle M. Hines; Steven J Moss; Jean-Marc Fritschy; Arnold Munnich; Jeanne Amiel; Steven A. Brown; Shiva K. Tyagarajan; Laurence Colleaux

The NONO protein has been characterized as an important transcriptional regulator in diverse cellular contexts. Here we show that loss of NONO function is a likely cause of human intellectual disability and that NONO-deficient mice have cognitive and affective deficits. Correspondingly, we find specific defects at inhibitory synapses, where NONO regulates synaptic transcription and gephyrin scaffold structure. Our data identify NONO as a possible neurodevelopmental disease gene and highlight the key role of the DBHS protein family in functional organization of GABAergic synapses.


European Journal of Human Genetics | 2016

A nonsense variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy

Lam Son Nguyen; Taiane Schneider; Marlène Rio; Sébastien Moutton; Karine Siquier-Pernet; Florine Verny; Nathalie Boddaert; Isabelle Desguerre; Arnold Munich; Jose Luis Rosa; Valérie Cormier-Daire; Laurence Colleaux

Megalencephaly is a congenital condition characterized by severe overdeveloped brain size. This phenotype is often caused by mutations affecting the RTK/PI3K/mTOR (receptor tyrosine kinase-phosphatidylinositol-3-kinase-AKT) signaling and its downstream pathway of mammalian target of rapamycin (mTOR). Here, using a whole-exome sequencing in a Moroccan consanguineous family, we show that a novel autosomal-recessive neurological condition characterized by megalencephaly, thick corpus callosum and severe intellectual disability is caused by a homozygous nonsense variant in the HERC1 gene. Assessment of the primary skin fibroblast from the proband revealed complete absence of the HERC1 protein. HERC1 is an ubiquitin ligase that interacts with tuberous sclerosis complex 2, an upstream negative regulator of the mTOR pathway. Our data further emphasize the role of the mTOR pathway in the regulation of brain development and the power of next-generation sequencing technique in elucidating the genetic etiology of autosomal-recessive disorders and suggest that HERC1 defect might be a novel cause of autosomal-recessive syndromic megalencephaly.


Human Mutation | 2013

Mutation in TTI2 Reveals a Role for Triple T Complex in Human Brain Development

Maéva Langouët; Abdelkrim Saadi; Guillaume Rieunier; Sébastien Moutton; Karine Siquier-Pernet; Marie Fernet; Patrick Nitschke; Arnold Munnich; Marc-Henri Stern; Malika Chaouch; Laurence Colleaux

Tel2‐interacting proteins 1 and 2 (TTI1 and TTI2) physically interact with telomere maintenance 2 (TEL2) to form a conserved trimeric complex called the Triple T complex. This complex is a master regulator of phosphoinositide‐3‐kinase‐related protein kinase (PIKKs) abundance and DNA damage response signaling. Using a combination of autozygosity mapping and high‐throughput sequencing in a large consanguineous multiplex family, we found that a missense c.1307T>A/p.I436N mutation in TTI2 causes a human autosomal recessive condition characterized by severe cognitive impairment, microcephaly, behavioral troubles, short stature, skeletal anomalies, and facial dysmorphic features. Immunoblotting experiment showed decreased amount of all Triple T complex components in the patient skin fibroblasts. Consistently, a drastically reduced steady‐state level of all PIKKs tested was also observed in the patient cells. Combined with previous observations, these findings emphasises the role of the TTI2 gene in the etiology of intellectual disability and further support the role of PIKK signaling in brain development and functioning.


Neurogenetics | 2017

Recurrent KIF2A mutations are responsible for classic lissencephaly

Mara Cavallin; Emilia K. Bijlsma; Adrienne El Morjani; Sébastien Moutton; Els Peeters; Camille Maillard; Jean Michel Pedespan; Anne-Marie Guerrot; Valérie Drouin-Garaud; Christine Coubes; David Geneviève; Christine Bole-Feysot; Cécile Fourrage; Julie Steffann; Nadia Bahi-Buisson

Kinesins play a critical role in the organization and dynamics of the microtubule cytoskeleton, making them central players in neuronal proliferation, neuronal migration, and postmigrational development. Recently, KIF2A mutations were identified in cortical malformation syndromes associated with microcephaly. Here, we detected two de novo p.Ser317Asn and p.His321Pro mutations in KIF2A in two patients with lissencephaly and microcephaly. In parallel, we re-evaluated the two previously reported cases showing de novo mutations of the same residues. The identification of mutations only in the residues Ser317 and His321 suggests these are hotspots for de novo mutations. Both mutations lead to a classic form of lissencephaly, with a posterior to anterior gradient, almost indistinguishable from LIS1-related lissencephaly. However, three fourths of patients also showed variable congenital and postnatal microcephaly, up to −5 SD. Located in the motor domain of the KIF2A protein, the Ser317 and His321 alterations are expected to disrupt binding or hydrolysis of ATP and consequently the MT depolymerizing activity. This report also establishes that KIF2A mutations represent significant causes of classic lissencephaly with microcephaly.


European Journal of Medical Genetics | 2012

Dysmorphic features in subtelomeric 20p13 deletion excluding JAG1: a recognizable microdeletion phenotype?

Sébastien Moutton; Caroline Rooryck; Jérôme Toutain; Dorothée Cailley; Julie Bouron; Frédéric Villega; Emmanuelle Taupiac; Didier Lacombe; Benoît Arveiler; Cyril Goizet

We report a 19 year-old patient carrying a terminal 20p microdeletion. She displayed clinical features resembling those of two other previously described patients. We suggest that a specific phenotype can be associated with this chromosomal anomaly. Mental retardation, epilepsy, and dysmorphic signs including low-set ears and overfolded helices seem highly characteristic of this syndrome and may define major diagnostic criteria of a recognizable phenotype. Delayed closure of fontanella, delayed permanent teeth eruption, visual disturbances, prominent ear lobes, prominent nasal root and ridge, thin upper lip and brachydactyly may represent inconstant minor criteria.


European Journal of Human Genetics | 2017

Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype

Fanny Morice-Picard; Giovanni Benard; Hamid Reza Rezvani; Eulalie Lasseaux; Delphine Simon; Sébastien Moutton; Caroline Rooryck; Didier Lacombe; Clarisse Baumann; Benoit Arveiler

The ubiquitin-proteasome pathway is involved in the pathogenesis of several neurogenetic diseases. We describe a Mauritanian patient harboring a homozygous deletion restricted to two contiguous genes HERC2 and OCA2 and presenting with severe developmental abnormalities. The deletion causes the complete loss of HERC2 protein function, an E3-ubiquitin ligase. HERC2 is known to target XPA and BRCA1 for degradation and a mechanism whereby it is involved in DNA repair and cell cycle regulation. We showed that loss of HERC2 function leads to the accumulation of XPA and BRCA1 in the patient’s fibroblasts and generates decreased sensitivity to apoptosis and increased level of DNA repair. Our data describe for the first time the phenotypic consequences, both at the clinical and cellular levels, of a complete loss of HERC2 function in a patient. They strongly suggest that profound ubiquitin ligase – associated dysfunction is responsible for the severe phenotype in this patient, and that dysfunction of this pathway may be involved in other patients with similar neurodevelopmental diseases.


Journal of Human Genetics | 2016

Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum

Sébastien Moutton; Patricia Fergelot; Sophie Naudion; Marie-Pierre Cordier; Guilhem Solé; Elodie Guerineau; Christophe Hubert; Caroline Rooryck; Marie-Laure Vuillaume; Nada Houcinat; Julie Deforges; Julie Bouron; Sylvie Devès; Martine Le Merrer; Albert David; David Geneviève; Fabienne Giuliano; Hubert Journel; André Mégarbané; Laurence Faivre; Nicolas Chassaing; Christine Francannet; Elisabeth Sarrazin; Eva-Lena Stattin; Jacqueline Vigneron; Danielle Leclair; Caroline Abadie; Pierre Sarda; Clarisse Baumann; Marie-Ange Delrue

Otopalatodigital spectrum disorders (OPDSD) constitute a group of dominant X-linked osteochondrodysplasias including four syndromes: otopalatodigital syndromes type 1 and type 2 (OPD1 and OPD2), frontometaphyseal dysplasia, and Melnick–Needles syndrome. These syndromes variably associate specific facial and extremities features, hearing loss, cleft palate, skeletal dysplasia and several malformations, and show important clinical overlap over the different entities. FLNA gain-of-function mutations were identified in these conditions. FLNA encodes filamin A, a scaffolding actin-binding protein. Here, we report phenotypic descriptions and molecular results of FLNA analysis in a large series of 27 probands hypothesized to be affected by OPDSD. We identified 11 different missense mutations in 15 unrelated probands (n=15/27, 56%), of which seven were novel, including one of unknown significance. Segregation analyses within families made possible investigating 20 additional relatives carrying a mutation. This series allows refining the phenotypic and mutational spectrum of FLNA mutations causing OPDSD, and providing suggestions to avoid the overdiagnosis of OPD1.


European Journal of Human Genetics | 2018

19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference

Aurélien Trimouille; Nada Houcinat; Marie Laure Vuillaume; Patricia Fergelot; Cécile Boucher; Jérôme Toutain; Cédric Le Caignec; Marie Vincent; Mathilde Nizon; Joris Andrieux; Clémence Vanlerberghe; Bruno Delobel; Bénédicte Duban; Sahar Mansour; Emma L. Baple; Colina McKeown; Gemma Poke; Kate Robertshaw; Eve Fifield; Antonella Fabretto; Vanna Pecile; Paolo Gasparini; Marco Carrozzi; Didier Lacombe; Benoit Arveiler; Caroline Rooryck; Sébastien Moutton

Syndromes caused by copy number variations are described as reciprocal when they result from deletions or duplications of the same chromosomal region. When comparing the phenotypes of these syndromes, various clinical features could be described as reversed, probably due to the opposite effect of these imbalances on the expression of genes located at this locus. The NFIX gene codes for a transcription factor implicated in neurogenesis and chondrocyte differentiation. Microdeletions and loss of function variants of NFIX are responsible for Sotos syndrome-2 (also described as Malan syndrome), a syndromic form of intellectual disability associated with overgrowth and macrocephaly. Here, we report a cohort of nine patients harboring microduplications encompassing NFIX. These patients exhibit variable intellectual disability, short stature and small head circumference, which can be described as a reversed Sotos syndrome-2 phenotype. Strikingly, such a reversed phenotype has already been described in patients harboring microduplications encompassing NSD1, the gene whose deletions and loss-of-function variants are responsible for classical Sotos syndrome. Even though the type/contre-type concept has been criticized, this model seems to give a plausible explanation for the pathogenicity of 19p13 microduplications, and the common phenotype observed in our cohort.


European Journal of Medical Genetics | 2018

Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant

Chloé Angelini; Julien Van Gils; Antoine Bigourdan; Pierre-Simon Jouk; Didier Lacombe; Patrice Menegon; Sébastien Moutton; Florence Riant; Guilhem Solé; Elisabeth Tournier-Lasserve; Aurélien Trimouille; Marie Vincent; Cyril Goizet

The CACNA1A gene encodes a calcium-dependent voltage channel, localized in neuronal cells. Pathogenic variants in this gene are known to lead to a broad clinical spectrum including episodic ataxia type 2, spinocerebellar ataxia type 6, familial hemiplegic migraine, and more recently epileptic encephalopathy. We report a large family revealing a wide variability of neurological manifestations associated with a CACNA1A missense pathogenic variant. The index case had early-onset epileptic encephalopathy with progressive cerebellar atrophy, although his mother and his great-grandmother suffered from paroxystic episodic ataxia. His grandfather and great grand-aunt reported no symptoms, but two of her sons displayed early-onset ataxia with intellectual disability. Two of her little daughters suffered from gait disorders, and also from epilepsy for one of them. All these relatives were carriers of the previously described heterozygous variant in CACNA1A gene. We report here the first family leading to major clinical variability and incomplete penetrance. Our family highlights the difficulties to provide accurate genetic counselling concerning prenatal diagnosis regarding highly variable severity of the clinical presentation.


Neuropathology and Applied Neurobiology | 2017

In utero seizures revealing dentato-olivary dysplasia caused by SCN2A mutation

Fanny Sauvestre; Sébastien Moutton; Catherine Badens; Bernard Broussin; Dominique Carles; Nada Houcinat; Caroline Lacoste; Florent Marguet; Christophe Pecheux; Laurent Villard; Fanny Pelluard; Annie Laquerrière; Gwenaëlle André

Most early-onset epileptic encephalopathies (EOEE) are caused by genetic defects. In the past, mutations, especially in genes encoding sodium channels, have been identified using linkage studies, array-CGH and more recently next-generation sequencing (NGS) [1]. Mutations in SCN2A gene have been identified in a wide variety of early-onset epileptic syndromes including benign familial neonatal infantile seizures (BFNIS) [2] and more severe forms leading to encephalopathy such as Ohtahara or West syndromes [3], epilepsy of infancy with migrating focal seizures (EIMFS) [4] and autism spectrum disorders [5]. In 2013, mutations in SCN2A gene were reported with dentato-olivary dysplasia (DOD) in a single family [6] but the link between DOD and severe EOEE needs to be confirmed [6]. This article is protected by copyright. All rights reserved.

Collaboration


Dive into the Sébastien Moutton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laurence Colleaux

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marlène Rio

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karine Siquier-Pernet

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge